fosinopril has been researched along with Cardiovascular Diseases in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 11 (57.89) | 29.6817 |
| 2010's | 5 (26.32) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dixon, SN; Fleet, JL; Garg, AX; Jain, AK; McIntyre, C; Oliver, M; Wald, R; Weir, MA | 1 |
| Atkinson, HH; Cesari, M; Di Bari, M; Kritchevsky, SB; Pahor, M; Penninx, BW; Tracy, RP | 1 |
| Cesari, M; Incalzi, RA; Pahor, M; Pedone, C | 1 |
| Cesari, M; Giovannini, S; Leeuwenburgh, C; Maggio, M; Marzetti, E; Pahor, M | 1 |
| Asselbergs, FW; Brouwers, FP; de Boer, RA; Gansevoort, RT; Hillege, HL; van Gilst, WH; van Veldhuisen, DJ | 1 |
| Cridlig, J; Kessler, M; Lehert, P; Rossignol, P; Zannad, F | 1 |
| Bicket, DP | 1 |
| Asselbergs, FW; de Jong, PE; de Zeeuw, D; Diercks, GF; Hillege, HL; Janssen, WM; van Boven, AJ; van Gilst, WH; van Veldhuisen, DJ; Voors, AA | 1 |
| Asselbergs, FW; Bakker, SJ; de Jong, PE; Geluk, CA; Hillege, HL; van Gilst, WH; Zijlstra, F | 1 |
| Asselbergs, FW; Atthobari, J; Boersma, C; de Jong, PE; de Jong-van den Berg, LT; de Vries, R; Gansevoort, RT; Hillege, HL; Postma, MJ; van Gilst, WH | 1 |
| Grünfeld, JP; Kessler, M; Lechat, P; Lehert, P; Leizorovicz, A; Thuilliez, C; Zannad, F | 2 |
| Basi, S; Fesler, P; Lewis, JB; Mimran, A | 1 |
| Zamorski, MA | 1 |
| Parving, HH | 1 |
| Bak, AA; Crijns, HJ; de Jong, PE; Diercks, GF; Janssen, WM; van Boven, AJ; van Gilst, WH | 1 |
| Avants, SK; Grupp, L; Margolin, A; Rinder, HM; Setaro, JF | 1 |
3 review(s) available for fosinopril and Cardiovascular Diseases
| Article | Year |
|---|---|
Using ACE inhibitors appropriately.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Captopril; Cardiovascular Diseases; Clinical Trials as Topic; Contraindications; Diabetic Nephropathies; Drug Costs; Enalapril; Fosinopril; Heart Failure; Humans; Hypertension; Indoles; Isoquinolines; Lisinopril; Meta-Analysis as Topic; Myocardial Infarction; Perindopril; Quinapril; Ramipril; Renin-Angiotensin System; Risk; Tetrahydroisoquinolines; United States | 2002 |
Microalbuminuria in type 2 diabetes and hypertension: a marker, treatment target, or innocent bystander?
Topics: Albuminuria; Antihypertensive Agents; Biomarkers; Blood Pressure; Cardiovascular Diseases; Clinical Trials as Topic; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Fosinopril; Glomerular Filtration Rate; Humans; Hypertension; Prevalence; Proteinuria | 2008 |
Calcium antagonists and cardiovascular risk in diabetes.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; Diabetes Complications; Drug Therapy, Combination; Europe; Fosinopril; Humans; Hypertension; Multicenter Studies as Topic; Randomized Controlled Trials as Topic | 1998 |
10 trial(s) available for fosinopril and Cardiovascular Diseases
| Article | Year |
|---|---|
Angiotensin-converting enzyme inhibition and novel cardiovascular risk biomarkers: results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Cardiovascular Diseases; Cross-Over Studies; Double-Blind Method; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Fosinopril; Humans; Male; Middle Aged; Risk Factors | 2009 |
ACE-inhibition and physical function: results from the Trial of Angiotensin-Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Cross-Over Studies; Double-Blind Method; Exercise Test; Female; Fosinopril; Hand Strength; Humans; Male; Middle Aged; North Carolina; Postural Balance | 2010 |
Effects of ACE-inhibition on IGF-1 and IGFBP-3 concentrations in older adults with high cardiovascular risk profile.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Cardiovascular Diseases; Cross-Over Studies; Double-Blind Method; Female; Fosinopril; Humans; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Male; Middle Aged; Risk Factors | 2010 |
Long-term effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria:Ten years of follow-up of Prevention of Renal and Vascular End-stage Disease Intervention Trial (PREVEND IT).
Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Cardiovascular Diseases; Female; Follow-Up Studies; Fosinopril; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pravastatin | 2011 |
Visit-to-visit blood pressure variability is a strong predictor of cardiovascular events in hemodialysis: insights from FOSIDIAL.
Topics: Aged; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Coronary Artery Disease; Female; Fosinopril; Humans; Hypertension; Incidence; Kidney Failure, Chronic; Linear Models; Male; Middle Aged; Models, Statistical; Office Visits; Peripheral Arterial Disease; Predictive Value of Tests; Renal Dialysis; Risk Factors; Stroke | 2012 |
Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria.
Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Cohort Studies; Double-Blind Method; Female; Follow-Up Studies; Fosinopril; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Life Tables; Male; Middle Aged; Pravastatin; Treatment Outcome | 2004 |
Impact of statins in microalbuminuric subjects with the metabolic syndrome: a substudy of the PREVEND Intervention Trial.
Topics: Albuminuria; Antihypertensive Agents; Cardiovascular Diseases; Coronary Disease; Double-Blind Method; Female; Fosinopril; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Metabolic Syndrome; Middle Aged; Pravastatin; Survival Analysis | 2005 |
Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiovascular Diseases; Clinical Protocols; Confidence Intervals; Data Interpretation, Statistical; Female; Forecasting; Fosinopril; Humans; Hypertension; Kidney Failure, Chronic; Male; Placebos; Renal Dialysis; Risk Factors; Time Factors; Treatment Outcome | 2006 |
CCBs vs ACE inhibitors in patients with diabetes.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Follow-Up Studies; Fosinopril; Humans; Hypertension; Risk Factors; Treatment Outcome | 1998 |
Rationale, design, and baseline characteristics of a trial of prevention of cardiovascular and renal disease with fosinopril and pravastatin in nonhypertensive, nonhypercholesterolemic subjects with microalbuminuria (the Prevention of REnal and Vascular E
Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cardiovascular Diseases; Double-Blind Method; Drug Therapy, Combination; Female; Fosinopril; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Kidney Diseases; Male; Middle Aged; Pravastatin; Randomized Controlled Trials as Topic; Research Design | 2000 |
6 other study(ies) available for fosinopril and Cardiovascular Diseases
| Article | Year |
|---|---|
Angiotensin Converting Enzyme Inhibitor Dialyzability and Outcomes in Older Patients Receiving Hemodialysis.
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Cardiovascular Diseases; Enalapril; Female; Fosinopril; Hemorheology; Humans; Kidney Failure, Chronic; Kidneys, Artificial; Lisinopril; Male; Middle Aged; Perindopril; Ramipril; Renal Dialysis; Retrospective Studies; Survival Analysis | 2015 |
[Microalbuminuria--an independent indication for administration of ACE inhibitors: role of fosinopril (PREVEND IT trial)].
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Clinical Trials as Topic; Fosinopril; Humans | 2005 |
Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal
Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Cost-Benefit Analysis; Female; Fosinopril; Health Care Costs; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Male; Mass Screening; Middle Aged; Netherlands; Pravastatin; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic | 2006 |
Predictors of cardiovascular events in patients with end-stage renal disease: an analysis from the Fosinopril in dialysis study.
Topics: Aged; Antihypertensive Agents; Cardiovascular Diseases; Female; Fosinopril; Humans; Kidney Failure, Chronic; Male; Models, Statistical; Multicenter Studies as Topic; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Renal Dialysis; Risk Factors | 2007 |
[Fosinopril in the cardiovascular management of elderly patients].
Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Diuretics; Drug Therapy, Combination; Female; Fosinopril; Heart Failure; Humans; Hypertension; Hypertension, Renal; Male | 1996 |
Cocaine, HIV, and their cardiovascular effects: is there a role for ACE-inhibitor therapy?
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Cocaine-Related Disorders; Drug Tolerance; Electrocardiography; Female; Fosinopril; HIV Seropositivity; Humans; Male; Middle Aged | 2000 |